Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	5/25/2006 8:43:56 PM
	of 3158

08:31 ET Angiotech Pharm guides Y06 EPS above consensus, revs in-line; co to acquire Quill Medical (ANPI) 13.73 :Co issues guidance for FY06 (Dec), sees EPS of $0.79-0.81 vs. $0.76 Reuters Estimates consensus; sees FY06 (Dec) revs of $325-335 mln vs. $333.63 mln consensus. Co also announced that it has entered into a definitive agreement to acquire privately held Quill Medical for US $40 mln in cash, plus certain future contingent payments based on product revs. Through this transaction, Co will acquire all of Quill's technology and intellectual property, including the Contour Threads product line. The acquisition of Quill is subject to customary closing conditions, including the final approval of the shareholders of Quill, and is expected to close by the third quarter of 2006.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next